SEATTLE -- Phase Genomics, Inc., a biotech company leading advancements in next-generation sequencing (NGS) solutions for genome assembly and analysis, today announced the launch of its new platform for precision oncology. The OncoTerra platform implements a rapid, cost-effective alternative to current cytogenomic analysis tools while unlocking information in even the most challenging of sample types. [...]

-- Results independently confirmed through live virus plaque-reduction assay -- -- Results published on BioRxiv and submitted to the FDA as part of pre-IND data package -- BETHESDA, Md. & SOUTH SAN FRANCISCO, Calif. -- Revelar Biotherapeutics, Inc. and Twist Bioscience Corporation (Nasdaq: TWST) today announced that RBT-0813 binds to and neutralizes the Omicron and Delta [...]

Company Provides 2022 Revenue Growth Outlook EMERYVILLE, Calif. -- Berkeley Lights, Inc., (Nasdaq: BLI), (“BLI” or “the Company”), a leader in digital cell biology, today announced that Eric D. Hobbs, Ph.D. will transition from his role as chief executive officer (CEO) and member of the board of directors to president of the Antibody Therapeutics business [...]

Partnership will Accelerate Next-Generation Sequencing into Fastest-Growing Area of Proteomics Market with Ultra-high Throughput, Ultra-high Plexity Workflow SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN) today announced it has entered into a definitive co-development agreement with SomaLogic to bring the SomaScan® Proteomics Assay onto Illumina's current and future high throughput next-generation sequencing (NGS) platforms. This partnership [...]

Co-developed and co-branded products to combine market-leading proteomic and genomic analysis platforms BOULDER, Colo. -- SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced a worldwide strategic collaboration with Illumina, a global next-generation sequencing technology leader. The multi-year partnership agreement will bring together genomics and proteomics technology platforms in a major commercial partnership [...]

BOULDER, Colo. -- Inscripta, Inc., The Digital Genome Engineering Company, today announced that it has appointed Kristala Prather, PhD, to serve on its Board of Directors. Dr. Prather is currently the Arthur D. Little Professor and Executive Officer of the Department of Chemical Engineering at MIT. “We are very excited to have Kris join our board. [...]

Florida, USA – BioTools, the pioneer in vibrational circular dichroism (VCD) technology and provider of proprietary instrumentation and analytical services for structure elucidation of chiral molecules, announces a collaboration with Schrödinger, Inc., whose physics-based software platform is transforming the way therapeutics and materials are discovered, to help chemists expedite the determination of the critical three-dimensional [...]

Akoya’s powerful new PhenoCycler™-Fusion system combined with Bio-Techne’s proven and established RNAScope® technology will enable comprehensive spatial phenotyping of RNA and protein biomarkers MARLBOROUGH, Mass. and MINNEAPOLIS -- Akoya Biosciences, Inc., (NASDAQ: AKYA), The Spatial Biology Company®, and Bio-Techne (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research [...]

Bio-Techne's proven and established RNAScope® technology combined with Akoya's powerful new PhenoCycler™-Fusion system will enable comprehensive spatial phenotyping of RNA and protein biomarkers MINNEAPOLIS and MARLBOROUGH, Mass. -- Bio-Techne (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, and Akoya Biosciences, Inc., (NASDAQ: AKYA), The [...]

Qlucore, provider of intuitive bioinformatics software for research and precision and companion diagnostics, announces the creation of a Scientific Advisory Board (SAB), consisting of five members, chaired by Carl-Johan Ivarsson, CEO of Qlucore. The SAB includes two of Qlucore’s founders; Thoas Fioretos and Magnus Fontes and three independent senior and renowned scientists and industry experts. [...]